Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
544.2 INR | +1.27% | +3.35% | +26.92% |
04-02 | Windlas Biotech Commissions New Injectible Manufacturing Unit | MT |
04-02 | Windlas Biotech Limited Commissions Its Injectable Facility | CI |
Sales 2022 | 4.66B 55.83M 76.03M | Sales 2023 | 5.13B 61.48M 83.72M | Capitalization | 4.71B 56.49M 76.94M |
---|---|---|---|---|---|
Net income 2022 | 381M 4.57M 6.22M | Net income 2023 | 426M 5.1M 6.95M | EV / Sales 2022 | 0.62 x |
Net cash position 2022 | 1.69B 20.3M 27.64M | Net cash position 2023 | 1.27B 15.21M 20.72M | EV / Sales 2023 | 0.67 x |
P/E ratio 2022 |
11.3
x | P/E ratio 2023 |
11.4
x | Employees | 1,049 |
Yield 2022 |
1.67% | Yield 2023 |
1.78% | Free-Float | 37.18% |
1 day | +1.27% | ||
1 week | +3.35% | ||
Current month | -1.56% | ||
1 month | +2.97% | ||
3 months | +6.04% | ||
6 months | +30.40% | ||
Current year | +26.92% |
Managers | Title | Age | Since |
---|---|---|---|
Komal Gupta
CEO | Chief Executive Officer | - | 15-10-15 |
Founder | 73 | 00-12-31 | |
Compliance Officer | - | 21-03-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 57 | 21-05-05 | |
Director/Board Member | 47 | 21-05-03 | |
Founder | 73 | 00-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 544.2 | +1.27% | 42,226 |
24-05-15 | 537.4 | +0.26% | 27,228 |
24-05-14 | 536 | +4.31% | 38,451 |
24-05-13 | 513.8 | +1.83% | 27,458 |
24-05-10 | 504.6 | +0.07% | 35,375 |
Delayed Quote NSE India S.E., May 16, 2024 at 07:40 am
More quotes1st Jan change | Capi. | |
---|---|---|
+26.92% | 134M | |
+32.36% | 709B | |
+30.77% | 595B | |
-1.60% | 367B | |
+20.07% | 334B | |
+6.04% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+9.27% | 171B |
- Stock Market
- Equities
- WINDLAS Stock